About us

We have developed a first-in-class therapeutical approach to tackle some of the world's most intractable diseases.

We are engineering circular RNAs that target structural elements in the RNA that are crucial for the development of disease and combining them with state-of-the-art delivery techniques. Our technology is based on the research from the Molecular Virology Group of Universitat Pompeu Fabra.

Our multidisciplinary team is committed to bring our technology to the hands of those who need it the most, the patients. Throughout this amazing journey, we also count with the support of our excellent  Advisory Board.

Team

Miriam Corredor Sánchez

PhD, MBI
Chief Executive Officer

Marc Talló Parra

PhD
Chief Scientific Officer

Ivan Dotu Rodriguez

PhD
VP of Research

Flor Alonso

PhD
Researcher

Marta Casas Vilaseca

MSc
Bioinformatician

Judit Tomsen Melero

PhD
Preclinical Project Manager

Advisory Board

Juana Díez Antón

PhD
Scientific Advisor

Miquel Angel Rubio

PhD, MD
Clinical Advisor

Scroll to Top